drugset / Trial / NCT00858988
Trial of Rifaximin in the Treatment of Tropical Enteropathy
Completed
147 enrolled
Washington University School of Medicine
Baylor College of Medicine · collabKamuzu University of Health Sciences · collabUnited States Department of Agriculture (USDA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether rifaximin is effective in the treatment of tropical enteropathy in a population of African children at high risk for this disease.
Timeline
- Start
- 2007-09
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifaximin | Other / unclassified | 100 mg | — |